glp 1 receptor agonists and dpp 4 inhibitors Comparison of GLP-1 DPP-4 DPP4 Inhibitor Mechanism of Action
Description
PMID: 34049922
Understanding how and why they complement each other underscores the fact that they are distinct drug classes
Combination drugs Medications like Qsymia and Contrave are more likely to be on formularies since theyre older and less expensive than GLP-1s
January 2025: Ozempics warning label was updated to include severe pancreatitis and kidney injuries
McMaster University and Evidence Prime, 2024
These findings suggest that survodutide has the potential to reduce liver fibrosis and improve liver function in patients with NASH, making it a promising therapeutic option for this complex liver disease [89]
